Copyright Reports & Markets. All rights reserved.

Global Hyperimmune Globulins Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Hyperimmune Globulins Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Hepatitis B Immunoglobulins
      • 1.2.2 Rabies Immunoglobulins
      • 1.2.3 Tetanus Immunoglobulins
      • 1.2.4 Rho(D) Immunoglobulins
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Government Institutions
      • 1.3.2 Private Sector
      • 1.3.3 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 CSL Behring
      • 2.1.1 Business Overview
      • 2.1.2 Hyperimmune Globulins Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Grifols
      • 2.2.1 Business Overview
      • 2.2.2 Hyperimmune Globulins Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Biotest
      • 2.3.1 Business Overview
      • 2.3.2 Hyperimmune Globulins Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Kedrion
      • 2.4.1 Business Overview
      • 2.4.2 Hyperimmune Globulins Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 CBPO
      • 2.5.1 Business Overview
      • 2.5.2 Hyperimmune Globulins Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Emergent (Cangene)
      • 2.6.1 Business Overview
      • 2.6.2 Hyperimmune Globulins Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Kamada
      • 2.7.1 Business Overview
      • 2.7.2 Hyperimmune Globulins Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 CNBG
      • 2.8.1 Business Overview
      • 2.8.2 Hyperimmune Globulins Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Hualan Bio
      • 2.9.1 Business Overview
      • 2.9.2 Hyperimmune Globulins Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Shanghai RAAS
      • 2.10.1 Business Overview
      • 2.10.2 Hyperimmune Globulins Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Sichuan Yuanda Shuyang
      • 2.11.1 Business Overview
      • 2.11.2 Hyperimmune Globulins Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 ADMA Biologics
      • 2.12.1 Business Overview
      • 2.12.2 Hyperimmune Globulins Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Hyperimmune Globulins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Hyperimmune Globulins Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Hyperimmune Globulins Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Hyperimmune Globulins Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Hyperimmune Globulins Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Hyperimmune Globulins Market Analysis by Regions

    • 4.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Hyperimmune Globulins Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Hyperimmune Globulins Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 4.3 Europe Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 4.5 South America Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    5 North America Hyperimmune Globulins by Countries

    • 5.1 North America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
      • 5.1.2 North America Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
    • 5.2 United States Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 5.3 Canada Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    6 Europe Hyperimmune Globulins by Countries

    • 6.1 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
      • 6.1.2 Europe Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
    • 6.2 Germany Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 6.3 UK Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 6.4 France Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 6.5 Russia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 6.6 Italy Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Hyperimmune Globulins by Countries

    • 7.1 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
      • 7.1.2 Asia-Pacific Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
    • 7.2 China Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 7.3 Japan Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 7.4 Korea Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 7.5 India Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    8 South America Hyperimmune Globulins by Countries

    • 8.1 South America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
      • 8.1.2 South America Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
    • 8.2 Brazil Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Hyperimmune Globulins by Countries

    • 9.1 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Hyperimmune Globulins Sales and Market Share by Countries (2014-2019)
      • 9.1.2 Middle East and Africa Hyperimmune Globulins Revenue and Market Share by Countries (2014-2019)
    • 9.2 Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 9.3 UAE Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Hyperimmune Globulins Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Hyperimmune Globulins Sales and Growth Rate (2014-2019)

    10 Global Hyperimmune Globulins Market Segment by Type

    • 10.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Hyperimmune Globulins Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2014-2019)
    • 10.2 Hepatitis B Immunoglobulins Sales Growth and Price
      • 10.2.1 Global Hepatitis B Immunoglobulins Sales Growth (2014-2019)
      • 10.2.2 Global Hepatitis B Immunoglobulins Price (2014-2019)
    • 10.3 Rabies Immunoglobulins Sales Growth and Price
      • 10.3.1 Global Rabies Immunoglobulins Sales Growth (2014-2019)
      • 10.3.2 Global Rabies Immunoglobulins Price (2014-2019)
    • 10.4 Tetanus Immunoglobulins Sales Growth and Price
      • 10.4.1 Global Tetanus Immunoglobulins Sales Growth (2014-2019)
      • 10.4.2 Global Tetanus Immunoglobulins Price (2014-2019)
    • 10.5 Rho(D) Immunoglobulins Sales Growth and Price
      • 10.5.1 Global Rho(D) Immunoglobulins Sales Growth (2014-2019)
      • 10.5.2 Global Rho(D) Immunoglobulins Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Hyperimmune Globulins Market Segment by Application

    • 11.1 Global Hyperimmune Globulins Sales Market Share by Application (2014-2019)
    • 11.2 Government Institutions Sales Growth (2014-2019)
    • 11.3 Private Sector Sales Growth (2014-2019)
    • 11.4 Other Sales Growth (2014-2019)

    12 Hyperimmune Globulins Market Forecast (2019-2024)

    • 12.1 Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Hyperimmune Globulins Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Hyperimmune Globulins Market Forecast (2019-2024)
      • 12.2.2 Europe Hyperimmune Globulins Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Hyperimmune Globulins Market Forecast (2019-2024)
      • 12.2.4 South America Hyperimmune Globulins Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Hyperimmune Globulins Market Forecast (2019-2024)
    • 12.3 Hyperimmune Globulins Market Forecast by Type (2019-2024)
      • 12.3.1 Global Hyperimmune Globulins Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Hyperimmune Globulins Market Share Forecast by Type (2019-2024)
    • 12.4 Hyperimmune Globulins Market Forecast by Application (2019-2024)
      • 12.4.1 Global Hyperimmune Globulins Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Hyperimmune Globulins Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

      Scope of the Report:
      Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
      The worldwide market for Hyperimmune Globulins is expected to grow at a CAGR of roughly 11.6% over the next five years, will reach 140 million US$ in 2024, from 82 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      CSL Behring
      Grifols
      Biotest
      Kedrion
      CBPO
      Emergent (Cangene)
      Kamada
      CNBG
      Hualan Bio
      Shanghai RAAS
      Sichuan Yuanda Shuyang
      ADMA Biologics

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Hepatitis B Immunoglobulins
      Rabies Immunoglobulins
      Tetanus Immunoglobulins
      Rho(D) Immunoglobulins
      Others

      Market Segment by Applications, can be divided into
      Government Institutions
      Private Sector
      Other

      There are 15 Chapters to deeply display the global Hyperimmune Globulins market.
      Chapter 1, to describe Hyperimmune Globulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Hyperimmune Globulins, with sales, revenue, and price of Hyperimmune Globulins, in 2017 and 2018;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2014 to 2019;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
      Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
      Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

      Buy now